Gene · 10419
Papers3,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Learned Conformational Space and Pharmacophore Into Molecular Foundational Model. | Adv Sci (Weinh) | 2026 | 41486619 | PubTator, text mining | PubMed |
| A Histone Code Functionally Linked to Replicative Senescence. | Aging Cell | 2026 | 41482664 | PubTator, text mining | PubMed |
| Mitochondrial VHL rewires cell metabolism in hypoxia. | Cell Metab | 2026 | 41435818 | PubTator, text mining | PubMed |
| Discovery of Bis-Acyl Hydrazides as Potent and Bioavailable MTA-Cooperative PRMT5 Inhibitors: A Case Study of Leveraging the Deuterium Kinetic Isotope Effect. | J Med Chem | 2026 | 41429045 | PubTator, text mining | PubMed |
| Discovery of novel selective PRMT5-MTA inhibitors through structure-based virtual screening. | Bioorg Chem | 2026 | 41406787 | PubTator, text mining | PubMed |
| COP9 signalosome and PRMT5 methylosome complexes are essential regulators of Lis1-dynein-based transport. | Cell Rep | 2026 | 41405990 | PubTator, text mining | PubMed |
| The crosstalk between ferroptosis and the immune system in urological cancers: Mechanisms, prognostic value, and therapeutic implications. | Crit Rev Oncol Hematol | 2026 | 41354411 | PubTator, text mining | PubMed |
| HnRNPA1 and HuR, but not PTB, modulate cap-independent translation initiation from sense and antisense human T-cell lymphotropic virus type 1 mRNAs. | FEBS J | 2026 | 41348149 | PubTator, text mining | PubMed |
| Current status and prospects of methylthioadenosine phosphorylase/protein arginine methyltransferase 5 target therapy. | Biochem Pharmacol | 2026 | 41314432 | PubTator, text mining | PubMed |
| DPSCs-Exos promote OPCs differentiation and white matter repair via Myl9-mediated PRMT5 nucleation after ischemic stroke. | J Cereb Blood Flow Metab | 2026 | 41272428 | PubTator, text mining | PubMed |
| Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC. | J Thorac Oncol | 2026 | 41260457 | PubTator, text mining | PubMed |
| Interferon-Driven Biomarkers and Synergistic Therapy for PRMT5 Inhibition in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | 41255229 | PubTator, text mining | PubMed |
| State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma. | Curr Opin Oncol | 2026 | 41222550 | PubTator, text mining | PubMed |
| PRDM15 inhibits responses of Tissue-Resident memory T cells by activating PVR/TIGIT axis to mediate gastric cancer immunosuppression. | J Adv Res | 2026 | 41213401 | PubTator, text mining | PubMed |
| The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinoma. | J Adv Res | 2026 | 41203070 | PubTator, text mining | PubMed |
| Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer. | Biochim Biophys Acta Mol Cell Res | 2026 | 41101730 | PubTator, text mining | PubMed |
| Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1. | J Exp Med | 2026 | 41081715 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors. | Genes Dis | 2026 | 41078957 | PubTator, text mining | PubMed |
| PRMT5 encourages cell migration and metastasis of tongue squamous cell carcinoma through methylating ΔNp63α. | Cell Death Differ | 2026 | 40913068 | PubTator, text mining | PubMed |
| MTAP Expression by Immunohistochemistry: A Novel Biomarker in NSCLC. | J Thorac Oncol | 2026 | 40850616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10419/papers?page=10